CompletedNCT01023659
Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
Medication studyAges 18+CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 893
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT01023659
- Official title
Show the full official title
An Innovative Approach to Maximizing the Impact of Efficacious Pharmacotherapies on Smoking Cessation Attempts.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including bupropion and varenicline.
Who was this study for?
Listed age limits: from 18 years.
